NEW YORK — Belgian molecular diagnostics software developer UgenTec said today that it has received a €490,000 ($550,000) grant from the Flemish government's Agency for Innovation and Entrepreneurship (VLAIO) to develop an infectious disease monitoring and prediction platform.
UgenTec said it will use the funding to support a three-year partnership with Hasselt University focused on developing tools for quality monitoring and laboratory management reporting, as well as tools for real-time monitoring and predictive modeling of respiratory infections based on the company's flagship FastFinder PCR diagnostics software platform.
The work will be conducted in collaboration with three Belgian hospitals — OLV Hospital, AZ Sint-Jan, Jessa Hospital — which are current commercial users of the FastFinder software.
"This grant enables our vision on how our platform can benefit not just individual labs, but serve as a tool for better healthcare management and provide tools for managing population health risks such as outbreaks," UgenTec CEO Steven Verhoeven said in a statement. "Commercially, these innovations are highly relevant as we're convinced that predictive modeling will help large diagnostic enterprises to better run their operations and pharmaceutical companies to improve their production processes."